Form 4: Colgate-Palmolive Director Defers Pay into Stock

Colgate-Palmolive Director Lorrie M. Norrington acquired 333 shares of common stock by deferring a portion of her annual cash retainer.

Summary

• Lorrie M. Norrington, a Director of Colgate-Palmolive Company (CL), acquired 333 shares of common stock.
• The transaction occurred on January 2, 2026, at a price of $78.66 per share.
• The acquisition was a result of deferring a portion of her annual cash retainer into a stock unit account, pursuant to the Deferred Compensation Plan for Non-Employee Directors.
• Following this transaction, Ms. Norrington directly beneficially owns 39,648 shares of Colgate-Palmolive common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged plan.

Sentiment

Score: 6

Explanation: A director's decision to defer cash compensation into company stock is generally viewed positively as it aligns their interests with shareholders, though this is a routine compensation event rather than a discretionary market purchase.

Positives

• A director increasing their stake in the company, even through deferred compensation, generally signals confidence in the company's future prospects.
• The deferral of cash compensation into stock aligns the director's financial interests more closely with those of the shareholders.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Management Comments

• The acquisition was a portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Industry Context

This type of insider transaction, where a non-employee director defers cash compensation into company stock, is a common practice across various industries, particularly within large, established corporations. It is a standard mechanism for aligning director incentives with shareholder value creation.

Comparison to Industry Standards

• It is a common practice for non-employee directors across many large-cap companies, including peers in the consumer staples sector like Procter & Gamble (PG) or Unilever (UL), to receive a portion of their compensation in equity or to defer cash compensation into company stock.
• This practice is designed to align the interests of the board with those of shareholders, similar to how directors at companies such as Johnson & Johnson (JNJ) or Kimberly-Clark (KMB) might structure their compensation.
• The use of a Rule 10b5-1 plan for such transactions is also standard practice, providing an affirmative defense against insider trading allegations by pre-scheduling trades.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by a director through a deferred compensation plan constitutes a related party transaction, as it involves a company insider and the issuer. This is a standard, disclosed compensation arrangement.

Stakeholder Impact

• Shareholders: Benefit from increased alignment of director interests with shareholder value due to the director's larger equity stake.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through a deferred compensation plan. While insider buying is generally positive, this specific transaction is a standard compensation event and does not provide new material information to warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Colgate-Palmolive, CL, Form 4, Insider Transaction, Director Stock Acquisition, Deferred Compensation, Equity Compensation, Beneficial Ownership, Corporate Governance